Tesamorelin 10mg
96.506% HPLC PurityA stabilised analogue of growth-hormone-releasing hormone (GHRH).

SKU: PCUK-IPAM10 • Batch: 100273
Selective growth-hormone secretagogue (GHRP) studied for its receptor selectivity relative to other GH-releasing peptides. 99.395% HPLC purity, COA verified.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
A stabilised analogue of growth-hormone-releasing hormone (GHRH).
The long-acting GHRH analogue on its own, without the Ipamorelin pairing.
A GHRH analogue paired with a GHRP in one vial, studied in growth-hormone research.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Ipamorelin is a selective pentapeptide growth-hormone secretagogue (GHRP) that acts as a ghrelin/growth-hormone secretagogue receptor agonist. Supplied as a lyophilised powder at 99.395% HPLC purity with full Certificate of Analysis (COA) documentation.
Our own Australian facility handles synthesis under GMP-compliant conditions, which is how chain-of-custody documentation stays unbroken from raw material to the vial you receive. Third-party testing — HPLC purity, mass spectrometry identity, LAL endotoxin (<1.0 EU/mg), sterility — happens on every batch before dispatch, at a lab we don't own.
Research has explored Ipamorelin's selective growth-hormone releasing activity, noted in the literature for minimal effect on cortisol and prolactin compared to earlier GHRPs. Strictly for in-vitro laboratory research only.
Ipamorelin is a selective pentapeptide growth-hormone secretagogue studied in preclinical research for its GH-releasing activity via the ghrelin receptor. All use is strictly for in-vitro laboratory research only.
Our Ipamorelin 10mg is independently verified at 99.395% HPLC purity. Each batch is tested by an accredited third-party laboratory and ships with a full Certificate of Analysis (COA).
Ipamorelin is a growth-hormone secretagogue (GHRP) acting on the ghrelin receptor, while CJC-1295 is a GHRH analogue. In research they are often studied together for their complementary mechanisms — see our CJC-1295 / Ipamorelin blend.
Store lyophilised at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Yes. Ipamorelin is legal to purchase in Australia for legitimate in-vitro laboratory and research purposes. It is not approved for human consumption or therapeutic use.
Ipamorelin 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to Ipamorelin. Provided for research context — not medical advice.
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL, et al. · European journal of endocrinology · 1998
PMID: 9849822
The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism
Lu Z, Ngan MP, Liu JYH, et al. · Physiology & behavior · 2024
PMID: 39043357
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
Tewari K, Liu TP, Im C, et al. · The American journal of sports medicine · 2026
PMID: 42578445
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats
Andersen NB, Malmlöf K, Johansen PB, et al. · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2001
PMID: 11735244
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.